1. Target deconvolution with matrix-augmented pooling strategy reveals cell-specific drug-protein interactions
- Author
-
Ji, Hongchao, Lu, Xue, Zhao, Shiji, Wang, Qiqi, Liao, Bin, Bauer, Ludwig G, Huber, Kilian VM, Luo, Ray, Tian, Ruijun, and Tan, Chris Soon Heng
- Subjects
Biological Sciences ,Medicinal and Biomolecular Chemistry ,Chemical Sciences ,Biotechnology ,5.1 Pharmaceuticals ,Development of treatments and therapeutic interventions ,cellular thermal shift assay ,chemical biology ,chemical proteomics ,drug development ,drug discovery ,protein mass spectrometry ,proteome thermal profiling ,target deconvolution ,Biochemistry and cell biology ,Medicinal and biomolecular chemistry - Abstract
Target deconvolution is a crucial but costly and time-consuming task that hinders large-scale profiling for drug discovery. We present a matrix-augmented pooling strategy (MAPS) which mixes multiple drugs into samples with optimized permutation and delineates targets of each drug simultaneously with mathematical processing. We validated this strategy with thermal proteome profiling (TPP) testing of 15 drugs concurrently, increasing experimental throughput by 60x while maintaining high sensitivity and specificity. Benefiting from the lower cost and higher throughput of MAPS, we performed target deconvolution of the 15 drugs across 5 cell lines. Our profiling revealed that drug-target interactions can differ vastly in targets and binding affinity across cell lines. We further validated BRAF and CSNK2A2 as potential off-targets of bafetinib and abemaciclib, respectively. This work represents the largest thermal profiling of structurally diverse drugs across multiple cell lines to date.
- Published
- 2023